Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy

The ability to target myeloid leukemia with immunotherapy would represent a significant therapeutic advance. We report here immunological analysis of clinical trials of primary and secondary vaccination with K562/GM-CSF immunotherapy in adult chronic phase chronic myeloid leukemia patients (CML-CP)...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, L, Smith, B D, Tsai, H-L, Yaghi, N K, Neela, P H, Moake, M, Fu, J, Kasamon, YL, Prince, G T, Goswami, M, Rosner, G L, Levitsky, H I, Hourigan, C S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789208/
https://www.ncbi.nlm.nih.gov/pubmed/24013666
http://dx.doi.org/10.1038/bcj.2013.44

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789208/
https://www.ncbi.nlm.nih.gov/pubmed/24013666
http://dx.doi.org/10.1038/bcj.2013.44

Ejemplares similares